Patents by Inventor Christoph Huwe

Christoph Huwe has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • New7&agr;, 17&agr;-bis-alkylated testosterone derivatives and their use in long-term therapy of androgen-dependent diseases
    Patent number: 6767903
    Abstract: The invention relates to new 7&agr;, 17&agr;, 17&bgr;-substituted testosterone derivatives of general formula (I) and their use as pure antiandrogens for the long-term therapy of androgen-dependent diseases, notably for the long-term antiandrogen therapy of prostate carcinoma.
    Type: Grant
    Filed: June 22, 2001
    Date of Patent: July 27, 2004
    Assignee: Schering AG
    Inventors: Arwed Cleve, Gerhard Sauer, Christoph Huwe, Karsten Parczyk, Jens Hoffmann, Martin Schneider
  • CDK-inhibitory pyrimidines, their production and use as pharmaceutical agents
    Publication number: 20040102630
    Abstract: This invention relates to pyrimidine derivatives of general formula I 1
    Type: Application
    Filed: November 7, 2002
    Publication date: May 27, 2004
    Applicant: Schering AG
    Inventors: Thomas Brumby, Rolf Jautelat, Olaf Prien, Martina Schafer, Gerhard Siemeister, Ulrich Lucking, Christoph Huwe
  • Piperazine derivatives that destabilize androgen receptors
    Publication number: 20040009969
    Abstract: This invention relates to new piperazine derivatives of general formula I, 1
    Type: Application
    Filed: November 22, 2002
    Publication date: January 15, 2004
    Applicant: Schering AG
    Inventors: Arwed Cleve, Christoph Huwe, Volker Schulze, Helmut Morack, Dieter Zopf, Jens Hoffmann, Andreas Reichel